Clinical Trial Update: Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating NPB-01 in bullous pemphigoid patients unresponsive to corticosteroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• NPB-01

Snippet

Sponsor: Nihon Pharmaceutical Co., Ltd | Conditions: Bullous Pemphigoid | Phase 3 | Status: COMPLETED